Quarterly results · NIVABUPA
NIVA BUPA HEALTH INS CO L reported revenue of ₹2,471 cr and net profit of ₹138 cr in Q1 FY27 (quarter ended 30 Jun 2026), +92.9% year on year. Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated automatically from exchange filings.
| Quarter | Q1 FY27 |
|---|---|
| Quarter ended | 30 Jun 2026 |
| Revenue | ₹2,471 cr |
| Revenue YoY | +27.9% |
| Operating profit | — |
| Operating margin | — |
| Net profit | ₹138 cr |
| Net profit YoY | +92.9% |
| Net profit QoQ | -60.1% |
| Net margin | 5.6% |
| Basic EPS | ₹0.75 |
| TTM revenue | ₹8,153 cr |
| TTM net profit | ₹467 cr |
| TTM net margin | 5.7% |
NIVA BUPA HEALTH INS CO L (NIVABUPA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹2,471 cr and a net profit of ₹138 cr, translating into earnings per share of ₹0.75.
Compared with the same quarter a year earlier, revenue grew strongly by +27.9% and net profit grew sharply by +92.9%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Revenue
₹2,471 cr
+27.9% YoY
Net profit
₹138 cr
+92.9% YoY
Operating profit
—
— YoY
EPS
₹0.75
+92.3% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹2,471 cr | — | ₹138 cr | — | 5.6% | ₹0.75 | +92.9% | -60.1% |
| Q4 FY262026-03-31 | ₹2,139 cr | — | ₹345 cr | — | 16.1% | ₹1.87 | +67.5% | +493.8% |
| Q3 FY262025-12-31 | ₹1,611 cr | — | -₹87.64 cr | — | -5.4% | ₹-0.47 | — | -222.7% |
| Q1 FY262025-06-30 | ₹1,932 cr | — | ₹71.44 cr | — | 3.7% | ₹0.39 | — | -65.3% |
| Q4 FY252025-03-31 | ₹1,671 cr | — | ₹206 cr | — | 12.3% | ₹1.13 | — | — |
| TTM (last 4 quarters) | ₹8,153 cr | — | ₹467 cr | — | 5.7% | ₹2.54 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|---|---|---|---|---|
| Revenue / Sales | ₹2,471 cr | ₹2,139 cr | ₹1,611 cr | ₹1,932 cr | ₹1,671 cr |
| Total expenses | ₹2,288 cr | ₹1,797 cr | ₹1,699 cr | ₹1,834 cr | ₹1,465 cr |
| Profit before tax | ₹184 cr | ₹341 cr | -₹87.64 cr | ₹97.92 cr | ₹206 cr |
| Tax expense | ₹45.94 cr | -₹3.97 cr | ₹0 cr | ₹26.48 cr | ₹0 cr |
| Effective tax rate | 25.0% | -1.2% | 0.0% | 27.0% | 0.0% |
| Net profit (PAT) | ₹138 cr | ₹345 cr | -₹87.64 cr | ₹71.44 cr | ₹206 cr |
| Net profit margin | 5.6% | 16.1% | -5.4% | 3.7% | 12.3% |
| Basic EPS | ₹0.75 | ₹1.87 | ₹-0.47 | ₹0.39 | ₹1.13 |
| Diluted EPS | ₹0.74 | ₹1.87 | ₹-0.47 | ₹0.39 | ₹1.13 |
| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|
| Revenue YoY | +27.9% | +28.0% | — | — | — |
| Revenue QoQ | +15.6% | +32.7% | -16.6% | +15.6% | — |
| Operating profit YoY | — | — | — | — | — |
| Operating profit QoQ | — | — | — | — | — |
| Net profit YoY | +92.9% | +67.5% | — | — | — |
| Net profit QoQ | -60.1% | +493.8% | -222.7% | -65.3% | — |
| EPS YoY | +92.3% | +65.5% | — | — | — |
| EPS QoQ | -59.9% | +497.9% | -220.5% | -65.5% | — |
Full-year performance for NIVA BUPA HEALTH INS CO L, useful for reading each quarter in context.
| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|---|---|---|---|
| Revenue / Sales | ₹7,106 cr | ₹5,691 cr | ₹4,427 cr | ₹2,799 cr |
| Total expenses | ₹6,979 cr | ₹5,477 cr | ₹4,345 cr | ₹2,786 cr |
| Operating profit (EBIT) | ₹183 cr | ₹277 cr | ₹135 cr | ₹57.67 cr |
| Operating margin | 2.6% | 4.9% | 3.1% | 2.1% |
| Interest cost | ₹55.72 cr | ₹63.66 cr | ₹53.22 cr | ₹45.13 cr |
| Profit before tax | ₹127 cr | ₹214 cr | ₹81.85 cr | ₹12.54 cr |
| Tax expense | -₹3.97 cr | ₹0 cr | ₹0 cr | ₹0 cr |
| Effective tax rate | -3.1% | 0.0% | 0.0% | 0.0% |
| Net profit (PAT) | ₹131 cr | ₹214 cr | ₹81.85 cr | ₹12.54 cr |
| Net profit margin | 1.8% | 3.8% | 1.8% | 0.4% |
| Basic EPS | ₹0.71 | ₹1.22 | ₹0.45 | ₹0.07 |
| Diluted EPS | ₹0.71 | ₹1.20 | ₹0.45 | ₹0.07 |
Topline for Q1 FY27 came in at ₹2,471 cr against ₹1,932 cr in Q1 FY26, and ₹2,139 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +15.6%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹2,288 cr, or 92.6% of revenue.
Net profit of ₹138 cr works out to a net margin of 5.6% compared with 3.7% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, NIVA BUPA HEALTH INS CO L reported profit before tax of ₹184 cr, a tax charge of ₹45.94 cr (effective rate 25.0%). Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹345 cr in Q4 FY26 to ₹138 cr in Q1 FY27, a change of -60.1%.
Across the trailing four quarters NIVA BUPA HEALTH INS CO L has generated revenue of ₹8,153 cr and net profit of ₹467 cr, a trailing net margin of 5.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹7,106 cr with net profit of ₹131 cr and EPS of ₹0.71, versus the prior year where revenue grew +24.9% and profit declined -38.8%.
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
NIVA BUPA HEALTH INS CO L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
No results report published for NIVABUPA yet — our desk covers each quarter within minutes of the filing.
In Q1 FY27 (quarter ended 30 Jun 2026), NIVA BUPA HEALTH INS CO L reported revenue of ₹2,471 cr and net profit of ₹138 cr, a change of +92.9% year on year on +27.9% revenue growth. EPS stood at ₹0.75.
NIVA BUPA HEALTH INS CO L posted a net profit margin of 5.6% and an operating margin of not available in Q1 FY27. On a trailing twelve-month basis, revenue is ₹8,153 cr and net profit ₹467 cr.
NIVA BUPA HEALTH INS CO L net profit changed -60.1% quarter on quarter, from ₹345 cr in Q4 FY26 to ₹138 cr in Q1 FY27.
NIVA BUPA HEALTH INS CO L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Results coverage for NIVABUPA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the NIVABUPA stock page.
For FY26, NIVA BUPA HEALTH INS CO L reported full-year revenue of ₹7,106 cr and net profit of ₹131 cr, with EPS of ₹0.71.
Past results dates for NIVABUPA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
